Clinical trial
Clinical Application Study of Transarterial Chemoembolization Containing Arsenic Trioxide in the Treatment of Hepatocellular Carcinoma
NCT02018757 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Application Study of Transarterial Chemoembolization Containing Arsenic Trioxide in the Treatment of Hepatocellular Carcinoma
- Lead sponsor
- First Hospital of China Medical University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- Not reported
- Enrollment
- 250 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.